Market Place
Sourcing Support
AbbVie`s Vyalev wins FDA nod in Parkinson`s after 2 rejections
18 Oct 2024 //
PRESS RELEASE
AbbVie Launches PRODUODOPA for People Living with Advanced Parkinson`s Disease
09 Jan 2024 //
PR NEWSWIRE
AbbVie to Present Data from Growing Neuroscience & Movement Disorders Portfolio
17 Sep 2022 //
PRESS RELEASE
AbbVie submits NDA for continuous, 24-hour infusion therapy in Parkinson`s
21 May 2022 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.